Compare stocks

Bachem Holding AG is a Swiss-based company specializing in the development and manufacturing of peptides and oligonucleotides, primarily serving the pharmaceutical and biotechnology industries. With its expertise in this niche area, Bachem offers products including active pharmaceutical ingredients (APIs) and research chemicals. Founded in 1971, the company has positioned itself as a key supplier for both commercial and clinical-stage clients. Bachem has production sites in Switzerland, Germany, the United Kingdom, and the United States, allowing for a robust global presence. The company's strategic positioning benefits from its focus on high-quality, innovative manufacturing processes that comply with stringent regulatory standards.

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.